Conversion Chemotherapy for Locally Advanced Pancreatic Carcinoma: FOLFIRINOX or Gemcitabine?

Kaibo Guo1, Jiamin Lu1, Xinlei Zhou1

  • 1Kaibo Guo, MD, Department of Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China; Jiamin Lu, MD, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China; Xinlei Zhou, MD, The Third Clinical Medical School, the Rehabilitation Medical School, Zhejiang Chinese Medical University, Hangzhou, China; and Song Zheng, PhD, Department of Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.

Abstract

No abstract available in PubMed .